{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:14:40Z","timestamp":1792815280489,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ejphar.2022.174987","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T10:57:25Z","timestamp":1651143445000},"page":"174987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A novel phosphodiesterase 9A inhibitor LW33 protects against ischemic stroke through the cGMP\/PKG\/CREB pathway"],"prefix":"10.1016","volume":"925","author":[{"given":"Jia-yi","family":"You","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-xia","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-nan","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gong-yun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-guo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2022.174987_bib1","doi-asserted-by":"crossref","first-page":"C343","DOI":"10.1152\/ajpcell.00095.2018","article-title":"Blood-brain barrier dysfunction in ischemic stroke: targeting tight junctions and transporters for vascular protection","volume":"315","author":"Abdullahi","year":"2018","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"9","key":"10.1016\/j.ejphar.2022.174987_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.174","article-title":"Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A","volume":"6","author":"Alexander","year":"2016","journal-title":"Transl. Psychiatry"},{"issue":"6535","key":"10.1016\/j.ejphar.2022.174987_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/376074a0","article-title":"Activity-dependent long-term enhancement of transmitter release by presynaptic 3',5'-cyclic GMP in cultured hippocampal neurons","volume":"376","author":"Arancio","year":"1995","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","article-title":"Sample size calculation in animal studies using resource equation Approach","volume":"24","author":"Arifin","year":"2017","journal-title":"Malays. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2022.174987_bib5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5812\/atr.10240","article-title":"Morphology of rat hippocampal CA1 neurons following modified two and four-vessels global ischemia models","volume":"2","author":"Atlasi","year":"2013","journal-title":"Arch. Trauma Res."},{"issue":"10","key":"10.1016\/j.ejphar.2022.174987_bib6","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.ejphar.2022.174987_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18030545","article-title":"More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.ejphar.2022.174987_bib8","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1128\/MCB.23.12.4066-4082.2003","article-title":"Synergism between calcium and cyclic GMP in cyclic AMP response element-dependent transcriptional regulation requires cooperation between CREB and C\/EBP-beta","volume":"23","author":"Chen","year":"2003","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib9","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1046\/j.1471-4159.2002.01080.x","article-title":"Nitric oxide regulates cGMP-dependent cAMP-responsive element binding protein phosphorylation and Bcl-2 expression in cerebellar neurons: implication for a survival role of nitric oxide","volume":"82","author":"Ciani","year":"2002","journal-title":"J. Neurochem."},{"issue":"25","key":"10.1016\/j.ejphar.2022.174987_bib10","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","article-title":"Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016","volume":"379","author":"Collaborators","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"18","author":"Collaborators","year":"2019","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.174987_bib12","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI120412","article-title":"Abolition of aberrant neurogenesis ameliorates cognitive impairment after stroke in mice","volume":"129","author":"Cuartero","year":"2019","journal-title":"J. Clin. Invest."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2022.174987_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the .NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"issue":"25","key":"10.1016\/j.ejphar.2022.174987_bib14","doi-asserted-by":"crossref","first-page":"15559","DOI":"10.1074\/jbc.273.25.15559","article-title":"Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase","volume":"273","author":"Fisher","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib15","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.conb.2011.12.005","article-title":"Sequence learning and the role of the hippocampus in rodent navigation","volume":"22","author":"Foster","year":"2012","journal-title":"Curr. Opin. Neurobiol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib16","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1096\/fj.201601209R","article-title":"Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke","volume":"31","author":"Fukuta","year":"2017","journal-title":"Faseb. J."},{"issue":"8","key":"10.1016\/j.ejphar.2022.174987_bib17","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1523\/JNEUROSCI.13-08-03510.1993","article-title":"Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury","volume":"13","author":"Goldberg","year":"1993","journal-title":"J. Neurosci."},{"issue":"9","key":"10.1016\/j.ejphar.2022.174987_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1097\/00004647-199709000-00007","article-title":"Neuronal nitric oxide synthase activation by vasoactive intestinal peptide in bovine cerebral arteries","volume":"17","author":"Gonzalez","year":"1997","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"9","key":"10.1016\/j.ejphar.2022.174987_bib19","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1177\/0271678X19877889","article-title":"Experimental cortical stroke induces aberrant increase of sharp-wave-associated ripples in the hippocampus and disrupts cortico-hippocampal communication","volume":"40","author":"He","year":"2020","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"11","key":"10.1016\/j.ejphar.2022.174987_bib20","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1097\/CCM.0000000000004597","article-title":"Management of acute ischemic stroke","volume":"48","author":"Herpich","year":"2020","journal-title":"Crit. Care Med."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174987_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-017-0245-y","article-title":"Reduced cGMP levels in CSF of AD patients correlate with severity of dementia and current depression","volume":"9","author":"Hesse","year":"2017","journal-title":"Alzheimer's Res. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1161\/STROKEAHA.115.011932","article-title":"Modeling ischemic stroke in vitro: status quo and future perspectives","volume":"47","author":"Holloway","year":"2016","journal-title":"Stroke"},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib23","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1124\/mol.115.099747","article-title":"Structural asymmetry of phosphodiesterase-9A and a unique pocket for selective binding of a potent enantiomeric inhibitor","volume":"88","author":"Huang","year":"2015","journal-title":"Mol. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2022.174987_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/cns.12864","article-title":"A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling","volume":"24","author":"Huang","year":"2018","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.ejphar.2022.174987_bib25","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.pneurobio.2017.10.001","article-title":"Blood-brain barrier dysfunction and recovery after ischemic stroke","volume":"163\u2013164","author":"Jiang","year":"2018","journal-title":"Prog. Neurobiol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/jcbfm.2013.203","article-title":"Hemorrhagic transformation after ischemic stroke in animals and humans","volume":"34","author":"Jickling","year":"2014","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"8","key":"10.1016\/j.ejphar.2022.174987_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201900045","article-title":"Initiated by CREB: resolving gene regulatory programs in learning and memory: switch in cofactors and transcription regulators between memory consolidation and maintenance network","volume":"41","author":"Kaldun","year":"2019","journal-title":"Bioessays"},{"issue":"12","key":"10.1016\/j.ejphar.2022.174987_bib28","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121654","article-title":"Early stroke induces long-term impairment of adult neurogenesis accompanied by hippocampal-mediated cognitive decline","volume":"8","author":"Kathner-Schaffert","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2022.174987_bib29","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cellsig.2017.11.004","article-title":"Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain","volume":"42","author":"Kelly","year":"2018","journal-title":"Cell. Signal."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000506396","article-title":"Global, regional and country-specific burden of ischaemic stroke, intracerebral haemorrhage and subarachnoid haemorrhage: a systematic analysis of the global burden of disease study 2017","volume":"54","author":"Krishnamurthi","year":"2020","journal-title":"Neuroepidemiology"},{"issue":"6","key":"10.1016\/j.ejphar.2022.174987_bib31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.neuropharm.2010.05.004","article-title":"Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues","volume":"59","author":"Lakics","year":"2010","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.ejphar.2022.174987_bib32","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1038\/nn.4661","article-title":"Viewpoints: how the hippocampus contributes to memory, navigation and cognition","volume":"20","author":"Lisman","year":"2017","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174987_bib33","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"issue":"4","key":"10.1016\/j.ejphar.2022.174987_bib34","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0896-6273(02)00828-0","article-title":"Function and regulation of CREB family transcription factors in the nervous system","volume":"35","author":"Lonze","year":"2002","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.ejphar.2022.174987_bib35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1152\/jn.2002.88.3.1270","article-title":"Ryanodine receptors contribute to cGMP-induced late-phase LTP and CREB phosphorylation in the hippocampus","volume":"88","author":"Lu","year":"2002","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.174987_bib36","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.ejphar.2022.174987_bib37","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/0033-295X.102.3.419","article-title":"Why there are complementary learning systems in the hippocampus and neocortex: insights from the successes and failures of connectionist models of learning and memory","volume":"102","author":"McClelland","year":"1995","journal-title":"Psychol. Rev."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174987_bib38","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.exer.2006.09.010","article-title":"cAMP-responsive element binding protein mediates a cGMP\/protein kinase G-dependent anti-apoptotic signal induced by nitric oxide in retinal neuro-glial progenitor cells","volume":"84","author":"Nagai-Kusuhara","year":"2007","journal-title":"Exp. Eye Res."},{"issue":"3","key":"10.1016\/j.ejphar.2022.174987_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/01.STR.16.3.459","article-title":"Cause of cerebral infarction in the carotid territory. Its relation to the size and the location of the infarct and to the underlying vascular lesion","volume":"16","author":"Olsen","year":"1985","journal-title":"Stroke"},{"key":"10.1016\/j.ejphar.2022.174987_bib40","doi-asserted-by":"crossref","first-page":"113518","DOI":"10.1016\/j.expneurol.2020.113518","article-title":"Emerging neuroprotective strategies for the treatment of ischemic stroke: an overview of clinical and preclinical studies","volume":"335","author":"Paul","year":"2021","journal-title":"Exp. Neurol."},{"issue":"6","key":"10.1016\/j.ejphar.2022.174987_bib41","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","article-title":"Blood-brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury","volume":"28","author":"Prakash","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib42","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/ana.410110509","article-title":"Temporal profile of neuronal damage in a model of transient forebrain ischemia","volume":"11","author":"Pulsinelli","year":"1982","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.ejphar.2022.174987_bib43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.tins.2019.05.006","article-title":"Refueling the ischemic CNS: guidance molecules for vascular repair","volume":"42","author":"Rust","year":"2019","journal-title":"Trends Neurosci."},{"issue":"7","key":"10.1016\/j.ejphar.2022.174987_bib44","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1515\/hsz-2018-0155","article-title":"From molecules to patients: exploring the therapeutic role of soluble guanylate cyclase stimulators","volume":"399","author":"Sandner","year":"2018","journal-title":"Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/14737175.2016.1134324","article-title":"Promoting recovery from ischemic stroke","volume":"16","author":"Schmidt","year":"2016","journal-title":"Expert Rev. Neurother."},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2174\/1567205011666140505100858","article-title":"A multicenter, double-blind, placebo-controlled trial of the PDE9A inhibitor, PF-04447943, in Alzheimer's disease","volume":"11","author":"Schwam","year":"2014","journal-title":"Curr. Alzheimer Res."},{"issue":"7","key":"10.1016\/j.ejphar.2022.174987_bib47","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jacc.2019.05.067","article-title":"Hemodynamic, hormonal, and renal actions of phosphodiesterase-9 inhibition in experimental heart failure","volume":"74","author":"Scott","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib48","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/cvr\/cvs327","article-title":"Transcriptional and post-transcriptional regulation of cGMP-dependent protein kinase (PKG-I): pathophysiological significance","volume":"97","author":"Sellak","year":"2013","journal-title":"Cardiovasc. Res."},{"issue":"24","key":"10.1016\/j.ejphar.2022.174987_bib49","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1021\/jm500836h","article-title":"Discovery of a phosphodiesterase 9A inhibitor as a potential hypoglycemic agent","volume":"57","author":"Shao","year":"2014","journal-title":"J. Med. Chem."},{"issue":"5965","key":"10.1016\/j.ejphar.2022.174987_bib50","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.1179735","article-title":"Local and long-range reciprocal regulation of cAMP and cGMP in axon\/dendrite formation","volume":"327","author":"Shelly","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib51","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00401-017-1667-0","article-title":"Ischemic stroke: experimental models and reality","volume":"133","author":"Sommer","year":"2017","journal-title":"Acta Neuropathol."},{"issue":"18","key":"10.1016\/j.ejphar.2022.174987_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186718","article-title":"Recent advances in cell-based therapies for ischemic stroke","volume":"21","author":"Suda","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2022.174987_bib53","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1124\/pr.108.000547","article-title":"Cerebral blood flow regulation by nitric oxide: recent advances","volume":"61","author":"Toda","year":"2009","journal-title":"Pharmacol. Rev."},{"issue":"7","key":"10.1016\/j.ejphar.2022.174987_bib54","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s10571-010-9545-5","article-title":"Damage to neurons and oligodendrocytes in the hippocampal CA1 sector after transient focal ischemia in rats","volume":"30","author":"Uchida","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.174987_bib55","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3109\/01677063.2011.630494","article-title":"The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 attenuates a scopolamine-induced deficit in a novel rodent attention task","volume":"25","author":"Vardigan","year":"2011","journal-title":"J. Neurogenet."},{"issue":"21","key":"10.1016\/j.ejphar.2022.174987_bib56","doi-asserted-by":"crossref","first-page":"9045","DOI":"10.1021\/jm3007799","volume":"55","author":"Verhoest","year":"2012","journal-title":"J. Med. Chem."},{"issue":"10258","key":"10.1016\/j.ejphar.2022.174987_bib58","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2022.174987_bib59","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0378-1119(03)00733-9","article-title":"Identification and characterization of a new human type 9 cGMP-specific phosphodiesterase splice variant (PDE9A5). Differential tissue distribution and subcellular localization of PDE9A variants","volume":"314","author":"Wang","year":"2003","journal-title":"Gene"},{"issue":"9","key":"10.1016\/j.ejphar.2022.174987_bib60","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/aps.2017.38","article-title":"C33(S), a novel PDE9A inhibitor, protects against rat cardiac hypertrophy through upregulating cGMP signaling","volume":"38","author":"Wang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.ejphar.2022.174987_bib61","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.apsb.2017.12.007","article-title":"Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors","volume":"8","author":"Wu","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"8","key":"10.1016\/j.ejphar.2022.174987_bib62","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1021\/acs.jmedchem.8b01041","article-title":"Discovery of potent, selective, and orally bioavailable inhibitors against phosphodiesterase-9, a novel target for the treatment of vascular dementia","volume":"62","author":"Wu","year":"2019","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2022.174987_bib63","doi-asserted-by":"crossref","first-page":"C135","DOI":"10.1152\/ajpcell.00136.2018","article-title":"Neuroinflammatory mechanisms of blood-brain barrier damage in ischemic stroke","volume":"316","author":"Yang","year":"2019","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"17","key":"10.1016\/j.ejphar.2022.174987_bib64","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176107","article-title":"Lessons from recent advances in ischemic stroke management and targeting Kv2.1 for neuroprotection","volume":"21","author":"Yeh","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2022.174987_bib65","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.redox.2016.12.034","article-title":"Neuroprotective action of N-acetyl serotonin in oxidative stress-induced apoptosis through the activation of both TrkB\/CREB\/BDNF pathway and Akt\/Nrf 2\/Antioxidant enzyme in neuronal cells","volume":"11","author":"Yoo","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2022.174987_bib66","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fncel.2018.00475","article-title":"TAT-Ngn2 enhances cognitive function recovery and regulates caspase-dependent and mitochondrial apoptotic pathways after experimental stroke","volume":"12","author":"Zhao","year":"2018","journal-title":"Front. Cell. Neurosci."},{"issue":"10204","key":"10.1016\/j.ejphar.2022.174987_bib67","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ejphar.2022.174987_bib68","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/aps.2018.23","article-title":"Pharmacological approaches promoting stem cell-based therapy following ischemic stroke insults","volume":"39","author":"Zhu","year":"2018","journal-title":"Acta Pharmacol. Sin."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:01:53Z","timestamp":1757977313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922002485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":67,"alternative-id":["S0014299922002485"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174987","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel phosphodiesterase 9A inhibitor LW33 protects against ischemic stroke through the cGMP\/PKG\/CREB pathway","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.174987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"174987"}}